30-Oct-2026 14:46:03

MAXHEALTH Q2 : CONS NET PROFIT DOWN 15.6% AT 414.45 CR (YOY), UP 28.3% (QOQ); GURUGRAM PROJECT COST AT RS 1,143 CR

Revenue up 20.3% at ₹2,569.21 Cr (YOY), up 8.6% (QOQ). Ebitda up 23.7% at ₹752.39 Cr (YOY), up 17.8% (QOQ); margins 29.3% v 28.5% (YOY), 27.0% (QOQ). Board approved ~₹93 Cr Noida and ~₹97 Cr Vaishali capex; Gurugram ~525-bed project cost revised to ~₹1,143 Cr.

Max Healthcare Institute Limited

← Back to feed